Welcome to our dedicated page for Illinois Tool Wk SEC filings (Ticker: ITW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for the Polymers & Fluids margin or the latest Automotive OEM backlog inside Illinois Tool Works’ 300-page annual report can feel like piecing together a complex puzzle. Because ITW touches everything from commercial kitchens to precision welding, its disclosures sprawl across dozens of forms—each critical, each time-sensitive.
Stock Titan solves that problem with AI-powered clarity. Our engine reads every Illinois Tool Works annual report 10-K, quarterly earnings report 10-Q filing, and 8-K material events, then surfaces what matters: segment revenue shifts, acquisition impacts, and currency headwinds—explained in plain English. Want to monitor Illinois Tool Works insider trading Form 4 transactions as they hit EDGAR? You’ll get real-time alerts the moment executives file. Trying to decode the proxy statement executive compensation tables? We translate footnotes into straightforward figures you can compare year over year.
Here’s how professionals use this page:
- Track Illinois Tool Works Form 4 insider transactions real-time to spot buying or selling before earnings.
- Compare quarter-over-quarter operating margin trends with our Illinois Tool Works earnings report filing analysis.
- Receive concise summaries that make understanding Illinois Tool Works SEC documents with AI faster than skimming hundreds of pages.
- Dive into Illinois Tool Works 8-K material events explained so you never miss a plant closure, acquisition, or leadership change.
- Review the Illinois Tool Works proxy statement executive compensation without juggling PDFs.
All filings, all segments, always current—and always explained simply. Explore Illinois Tool Works SEC filings today and make informed decisions without the paperwork overload.
Illinois Tool Works (ITW) reported solid Q3 results with operating revenue of $4,059 million, up 2.3% year over year, and operating income of $1,112 million, up 5.7%. Operating margin expanded to 27.4% from 26.5% as enterprise initiatives offset higher employee-related costs.
Diluted EPS was $2.81 versus $3.91 a year ago; the prior year included a sizable gain tied to the Wilsonart transaction. Segment performance was broad-based: Automotive OEM, Welding, Specialty Products, and Food Equipment grew, while Polymers & Fluids, Construction Products, and Test & Measurement and Electronics were softer. Year-to-date operating cash flow was $2,163 million.
The company repurchased ~1.5 million shares for $375 million in Q3 and declared dividends of $1.61 per share. Debt totaled $8,942 million, reflecting Euro note issuances and an amended Euro Credit Agreement now maturing as late as 2027. Shares outstanding were 290.1 million as of September 30, 2025.
Illinois Tool Works (ITW) furnished an update on its business by announcing its third‑quarter 2025 results, disclosed in a press release furnished as Exhibit 99.1.
The company highlighted several non‑GAAP measures used to evaluate performance. Free cash flow is defined as net cash provided by operating activities less additions to plant and equipment. After‑tax ROIC is defined as operating income after taxes divided by average invested capital and is annualized in interim periods; it excludes net discrete tax benefits of $27 million in Q3 2025 and $21 million in Q1 2025, and excludes $121 million of net discrete tax benefits in Q3 2024 for comparability. The company also presented diluted EPS for 2024 periods excluding the sale of its noncontrolling interest in Wilsonart International Holdings LLC and the cumulative effect of a change in inventory accounting method.
Randall J. Scheuneman, VP & Chief Accounting Officer of Illinois Tool Works Inc. (ITW), reported option exercise and a subsequent sale on 09/11/2025. He exercised 6,802 employee stock options with an exercise price of $128 per share and acquired 6,802 common shares. The same number of shares (6,802) were sold that day at a weighted average price reported as $265.08, with execution prices ranging from $265.06 to $265.15. Following these transactions Scheuneman beneficially owned 10,314 shares. The filing includes a remark that the options vested in four equal annual installments beginning one year from the grant date.
Illinois Tool Works Inc. (ITW) reported a proposed insider sale under Rule 144: 6,802 common shares are scheduled for sale on 09/11/2025 through Fidelity Brokerage Services, with an aggregate market value of $1,803,069.97. The shares to be sold were acquired in connection with an option (granted 02/10/2017) and the table indicates cash payment at the time of the reported sale. No other sales by the same person in the past three months are reported, and the filer certifies no undisclosed material adverse information about the issuer.
Illinois Tool Works director E. Scott Santi reported a non-derivative transaction on 08/21/2025 in which 3,790 shares of Common Stock were disposed of as a gift (Code G) at $0. After the transaction he beneficially owned 258,564 shares, which includes 4,545 shares of deferred stock held under the ITW Directors' Deferred Fee Plan as of the same date. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
Form 8-K (dated 30 Jul 2025) reports that Illinois Tool Works (ITW) released its Q2 2025 results via the press release furnished as Exhibit 99.1. The filing itself does not repeat revenue, EPS or cash-flow figures, directing investors to the exhibit for full detail.
Management reiterates two principal non-GAAP metrics: Free Cash Flow—defined as operating cash flow minus capex—to evaluate capacity for dividends, buybacks, acquisitions and debt pay-downs; and After-tax ROIC—operating income after taxes divided by average invested capital—to measure capital efficiency. Reconciliations to the nearest GAAP measures are provided in the press release.
The company also discloses adjustments that exclude discrete tax benefits of $21 million (Q1-25) and $121 million (Q3-24), plus effects from an inventory accounting change and the Wilsonart stake sale, to enhance comparability of trailing twelve-month diluted EPS.